Solvay Pharmaceuticals, Inc. Launches IsItLowT.com Web Site to ...

Tag : Pharmaceuticals

MARIETTA, Ga. , Aug. 21 /PRNewswire-FirstCall/ -- Solvay Pharmaceuticals, Inc. launched anew multi-media Web site, http://www.IsItLowT.com , to educate men and health care professionals about lowtestosterone (Low T). Low T, also known as hypogonadism, is acondition where a man's body does not produce enough testosterone.An estimated 90 percent of the more than 13 million American menwho suffer from Low T remain untreated.
"There is a lack of awareness on low testosterone in this country,and many especially do not realize that low testosterone levels canbe associated with other serious medical conditions, such as type 2diabetes and obesity," says Dr. Chad Ritenour , assistant professor and director of Men's Health Center for theDepartment of Urology at Emory University , Atlanta . "More tools and information are needed to help men and theirpartners recognize the symptoms of low testosterone and initiate aconversation with their physician about having their testosteronelevels checked through a simple blood test."
With symptoms that include decreased sex drive, loss of energy,body changes, depressed mood and sexual dysfunction, many men andtheir spouses are unaware of the condition. IsItLowT.com ( http://www.IsItLowT.com ) is a comprehensive Web site that is designed to provideeasy-to-understand information on Low T, including the signs andsymptoms of the condition, how it is diagnosed through a bloodtest, and treatment options available for men. The "Low T Quiz"featured on the Web site provides an online assessment of symptomsassociated with Low T. Spouses who suspect their male partner issuffering from Low T will also benefit from learning how they cantalk about the condition.
"We are pleased to launch IsItLowT.com as part of our ongoingcommitment to health education on low testosterone, a conditionthat can significantly impact a man's health," said Dr. Stephen Hill , president and chief executive officer, Solvay Pharmaceuticals,Inc. "We believe that IsItLowT.com will fulfill an unmet need inthe resources available for men, their spouses and health careprofessionals by providing them with the information to understandLow T and facilitate a dialogue."
About Low Testosterone
It is estimated that hypogonadism, also known as low testosterone,affects more than 13 million men in the United States age 45 and older. Because signs and symptoms of low testosteroneare subtle and often overlap with other common medical conditions,low testosterone is frequently undiagnosed. Signs and symptoms oflow testosterone include low sex drive, erectile dysfunction,fatigue, depressed mood, reduced muscle mass and strength,increased fat body mass and decreased bone mineral density.
Men with chronic conditions, such as obesity, diabetes, high bloodpressure, high cholesterol and asthma/COPD, are also more likely tohave low testosterone compared to other men. Below normal levels oftestosterone can be confirmed by a blood test.
About Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc., of Marietta, Georgia is the U.S. subsidiary of Solvay Pharmaceuticals. For moreinformation, visit www.solvaypharmaceuticals-us.com .
Solvay Pharmaceuticals is a research driven group of companies thatconstitute the global pharmaceutical business of the Solvay Group.The company seeks to fulfill carefully selected, unmet medicalneeds in the therapeutic areas of neuroscience, cardio-metabolic,influenza vaccines, gastroenterology, and men's and women's health.Its 2007 sales were EUR 2.6 billion and it employs more than 9,000 people worldwide. For moreinformation, visit www.solvaypharmaceuticals.com .
SOLVAY is an international chemical and pharmaceutical Group withheadquarters in Brussels . It employs more than 28,000 people in 50 countries. In 2007, itsconsolidated sales amounted to EUR 9.6 billion , generated by its three sectors of activity: Chemicals, Plasticsand Pharmaceuticals. Solvay (NYSE Euronext: SOLB.BE Brussels . Details are available at www.solvay.com .
SOURCE Solvay Pharmaceuticals, Inc.